Cargando…
Treatment with Activated Protein C (aPC) Is Protective during the Development of Myocardial Fibrosis: An Angiotensin II Infusion Model in Mice
AIMS: Myocardial fibrosis contributes to the development of heart failure. Activated Protein C (aPC) is a circulating anticoagulant with anti-inflammatory and cytoprotective properties. Using a model of myocardial fibrosis second to Angiotensin II (AngII) infusion, we investigated the novel therapeu...
Autores principales: | Sopel, Mryanda J., Rosin, Nicole L., Falkenham, Alec G., Bezuhly, Michael, Esmon, Charles T., Lee, Timothy D. G., Liwski, Robert S., Légaré, Jean-Francois |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446915/ https://www.ncbi.nlm.nih.gov/pubmed/23029168 http://dx.doi.org/10.1371/journal.pone.0045663 |
Ejemplares similares
-
Antibody therapy can enhance AngiotensinII-induced myocardial fibrosis
por: Rosin, Nicole L, et al.
Publicado: (2014) -
Connective tissue growth factor expression after angiotensin II exposure is dependent on transforming growth factor-β signaling via the canonical Smad-dependent pathway in hypertensive induced myocardial fibrosis
por: Wong, Chloe Kok Sum, et al.
Publicado: (2018) -
Modulation of angiotensin II signaling in the prevention of fibrosis
por: Murphy, Amanda M, et al.
Publicado: (2015) -
Factor VII, EPCR, aPC Modulators: novel treatment for neuroinflammation
por: Golderman, Valery, et al.
Publicado: (2022) -
Effects of rikkunshito on renal fibrosis and inflammation in angiotensin II-infused mice
por: Azushima, Kengo, et al.
Publicado: (2019)